China SXT Pharmaceuticals Inc (SXTC)
0.43
-0.03
(-6.54%)
USD |
NASDAQ |
Nov 14, 16:00
0.43
0.00 (0.00%)
After-Hours: 20:00
China SXT Pharmaceuticals Total Assets (Quarterly): 23.13M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 23.13M |
| September 30, 2023 | 14.59M |
| September 30, 2023 | 14.59M |
| March 31, 2023 | 29.55M |
| September 30, 2022 | 22.18M |
| September 30, 2022 | 22.18M |
| March 31, 2022 | 33.55M |
| September 30, 2021 | 22.67M |
| September 30, 2021 | 22.67M |
| March 31, 2021 | 34.55M |
| Date | Value |
|---|---|
| September 30, 2020 | 24.04M |
| September 30, 2020 | 24.04M |
| March 31, 2020 | 21.70M |
| September 30, 2019 | 23.05M |
| September 30, 2019 | 23.05M |
| March 31, 2019 | 17.47M |
| September 30, 2018 | 7.951M |
| September 30, 2018 | 7.951M |
| March 31, 2018 | 7.658M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.59M
Minimum
Sep 2023
34.55M
Maximum
Mar 2021
23.80M
Average
22.67M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 12.90B |
| CASI Pharmaceuticals Inc | 51.27M |
| Zai Lab Ltd | 987.37M |
| Adagene Inc | 100.78M |
| LakeShore Biopharma Co Ltd | 220.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.197M |
| Shareholders Equity (Quarterly) | 13.93M |
| Debt to Equity Ratio | 0.1731 |
| Current Ratio | 1.599 |
| Net Debt Paydown Yield | -10.78% |